Theodor Krantz Sells 15,000 Shares of Cognex Corporation (CGNX) Stock

Cognex Corporation (NASDAQ:CGNX) Director Theodor Krantz sold 15,000 shares of the company’s stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $134.05, for a total value of $2,010,750.00. Following the completion of the sale, the director now owns 26,250 shares of the company’s stock, valued at approximately $3,518,812.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Cognex Corporation (NASDAQ CGNX) opened at $137.73 on Wednesday. Cognex Corporation has a 1 year low of $57.12 and a 1 year high of $140.94. The stock has a market capitalization of $11,905.66, a PE ratio of 50.74 and a beta of 1.48.

Shares of Cognex Corporation are set to split on the morning of Monday, December 4th. The 2-1 split was announced on Monday, October 30th. The newly minted shares will be distributed to shareholders after the closing bell on Friday, December 1st.

Cognex Corporation (NASDAQ:CGNX) last released its earnings results on Monday, October 30th. The scientific and technical instruments company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.09. Cognex Corporation had a return on equity of 23.31% and a net margin of 34.77%. The firm had revenue of $259.74 million during the quarter, compared to analysts’ expectations of $255.95 million. During the same quarter last year, the business posted $0.61 earnings per share. The firm’s revenue was up 75.6% on a year-over-year basis. analysts expect that Cognex Corporation will post 2.77 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 1st. Investors of record on Friday, November 17th will be paid a dividend of $0.09 per share. The ex-dividend date of this dividend is Thursday, November 16th. This is a positive change from Cognex Corporation’s previous quarterly dividend of $0.09. This represents a $0.36 dividend on an annualized basis and a yield of 0.26%. Cognex Corporation’s dividend payout ratio is presently 12.55%.

ILLEGAL ACTIVITY WARNING: “Theodor Krantz Sells 15,000 Shares of Cognex Corporation (CGNX) Stock” was first posted by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.themarketsdaily.com/2017/11/15/theodor-krantz-sells-15000-shares-of-cognex-corporation-cgnx-stock.html.

Institutional investors have recently made changes to their positions in the stock. The Manufacturers Life Insurance Company boosted its stake in Cognex Corporation by 1.9% during the second quarter. The Manufacturers Life Insurance Company now owns 133,670 shares of the scientific and technical instruments company’s stock valued at $11,349,000 after buying an additional 2,551 shares during the last quarter. Airain ltd bought a new position in Cognex Corporation during the second quarter valued at approximately $1,074,000. Prudential Financial Inc. boosted its stake in Cognex Corporation by 24.8% during the second quarter. Prudential Financial Inc. now owns 427,606 shares of the scientific and technical instruments company’s stock valued at $36,303,000 after buying an additional 84,976 shares during the last quarter. State Street Corp boosted its stake in Cognex Corporation by 2.2% during the second quarter. State Street Corp now owns 2,169,073 shares of the scientific and technical instruments company’s stock valued at $184,153,000 after buying an additional 45,840 shares during the last quarter. Finally, Shelton Capital Management bought a new position in Cognex Corporation during the second quarter valued at approximately $550,000. 85.51% of the stock is owned by institutional investors.

A number of brokerages have commented on CGNX. Zacks Investment Research cut Cognex Corporation from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. J P Morgan Chase & Co cut Cognex Corporation from a “neutral” rating to an “underweight” rating and set a $125.00 price target for the company. in a research report on Wednesday, November 8th. BidaskClub upgraded Cognex Corporation from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 4th. Cowen and Company upped their price target on Cognex Corporation from $100.00 to $135.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 2nd. Finally, Robert W. Baird upped their price target on Cognex Corporation from $100.00 to $124.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 31st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $106.88.

Cognex Corporation Company Profile

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Insider Buying and Selling by Quarter for Cognex Corporation (NASDAQ:CGNX)

Receive News & Ratings for Cognex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply